Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Satya Dash; Sarah Crisp; Sara Hartnell; Sarah Donald; Katy Davenport; David Simmons; Mark Evans

doi:10.1016/j.diabres.2011.11.008

Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Satya Dash
, Sarah Crisp
, Sara Hartnell
, Sarah Donald
, Katy Davenport
, David Simmons
, Mark Evans

School of Medicine

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly. We describe two cases of patients on CSII with persistent post-prandial hyperglycaemia despite varying insulin doses and timing. Treatment with acarbose improved their glycaemic control.

Original language	English
Pages (from-to)	e49-e51
Number of pages	3
Journal	Diabetes Research and Clinical Practice
Volume	95
Issue number	3
DOIs	https://doi.org/10.1016/j.diabres.2011.11.008
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

acarbose
diabetes
hyperglycemia
insulin pumps

Access to Document

10.1016/j.diabres.2011.11.008

http://ezproxy.uws.edu.au/login?url=http://doi.org/10.1016/j.diabres.2011.11.008

Cite this

@article{17b58754fcb4409282ebe60a77cc0800,

title = "Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion",

abstract = "Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly. We describe two cases of patients on CSII with persistent post-prandial hyperglycaemia despite varying insulin doses and timing. Treatment with acarbose improved their glycaemic control.",

keywords = "acarbose, diabetes, hyperglycemia, insulin pumps",

author = "Satya Dash and Sarah Crisp and Sara Hartnell and Sarah Donald and Katy Davenport and David Simmons and Mark Evans",

year = "2012",

doi = "10.1016/j.diabres.2011.11.008",

language = "English",

volume = "95",

pages = "e49--e51",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

AU - Dash, Satya

AU - Crisp, Sarah

AU - Hartnell, Sara

AU - Donald, Sarah

AU - Davenport, Katy

AU - Simmons, David

AU - Evans, Mark

PY - 2012

Y1 - 2012

N2 - Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly. We describe two cases of patients on CSII with persistent post-prandial hyperglycaemia despite varying insulin doses and timing. Treatment with acarbose improved their glycaemic control.

AB - Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly. We describe two cases of patients on CSII with persistent post-prandial hyperglycaemia despite varying insulin doses and timing. Treatment with acarbose improved their glycaemic control.

KW - acarbose

KW - diabetes

KW - hyperglycemia

KW - insulin pumps

UR - http://handle.uws.edu.au:8081/1959.7/uws:31750

U2 - 10.1016/j.diabres.2011.11.008

DO - 10.1016/j.diabres.2011.11.008

M3 - Article

C2 - 22136721

SN - 0168-8227

VL - 95

SP - e49-e51

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

IS - 3

ER -

Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this